Substantial doubt about the company's ability to continue as a going concern.
“In connection with our assessment of going concern considerations in accordance with ASC 205-40, "Presentation of Financial Statements — Going Concern," management has determined that the mandatory liquidation date and subsequent dissolution, should a Business Combination not occur, raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The closing range uses available history since Dec 9, 2025; less than a full year is stored.
Crown Reserve Acquisition Corp. I amended its Business Combination Agreement with CRAC Merger Sub Inc. and Carvix, Inc., extending the Outside Date from September 30, 2026 to the later of February 10, 2027 and the date required under the Pre-Domestication Organizational Documents.
Useful current figures from the complete screener profile.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Illustrative technical + ownership context — a signal mix, not investment advice.
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CRAC
this stock
Crown Reserve Acquisition Corp. I
|
$229.95M | +3.4% | — | — | 0.1% |
|
VYLR
Vylor Inc.
|
$48.09B | — | — | — | 2.1% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$652.61M | +3.5% | — | — | 0.0% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$606.10M | +3.4% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Crown Reserve Acquisition Corp. I amended its Business Combination Agreement with CRAC Merger Sub Inc. and Carvix, Inc., extending the Outside Date from September 30, 2026 to the later of February 10, 2027 and the date required under the Pre-Domestication Organizational Documents.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CRAC | +0.0% | +0.2% | +2.7% | +0.1% | +3.4% |
| SPY | +3.3% | -1.9% | +1.5% | +0.2% | +11.0% |
| vs SPY | -3.3% | +2.1% | +1.2% | -0.1% | -7.6% |
